Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over

Detalles Bibliográficos
Autores principales: Alicandro, Gianfranco, Daccó, Valeria, Cariani, Lisa, Contarini, Martina, Morlacchi, Letizia Corinna, Rosazza, Chiara, Sciarrabba, Calogero Sathya, Ferraro, Federica, Lanfranchi, Chiara, Orena, Beatrice Silvia, Gramegna, Andrea, Blasi, Francesco, Colombo, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847104/
https://www.ncbi.nlm.nih.gov/pubmed/35256306
http://dx.doi.org/10.1016/j.jcf.2022.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847104/
https://www.ncbi.nlm.nih.gov/pubmed/35256306
http://dx.doi.org/10.1016/j.jcf.2022.02.009

Ejemplares similares